Infection with Histoplasma capsulatum: Host-fungus interface

Revista Iberoamericana de Micologia

Volumn 15, Issue 4, 1998, Pages 256-260

  Allendoerfer, Ruth ^a   Deepe Jr , George S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

B cells; Cytokines; Histoplasma capsulatum; Immune response; Phagocytes; T cells

Indexed keywords

EID: 2742580668     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Maresca B, Kobayashi GS. Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi. Microbiol Rev 1989; 53: 186-209.
2. Deepe GS Jr, Bullock WE. Histoplasmosis: a granulomatous inflammatory response. In Gallin JI, Goldstein LM, Snyderman R. (Eds.) Inflammation. Basic Principles and Clinical Correlates (2nd ed). New York, Raven Press, 1992. 943-948
3. Procknow JJ, Page MI, Loosli CG. Early pathogenesis of experimental histoplasmosis. Arch Pathol 1960; 69: 413-426.
4. Baughman RP, Kim CK, Vinegar A, Hendricks DE, Schmidt DJ, Bullock WE. The pathogenesis of experimental pulmonary histoplasmosis. Correlative studies of histopathology, bronchoalveolar lavage and respiratory function. Am Rev Resp Dis 1986; 134: 771-776
5. Cain JA, Deepe GS Jr Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun 1998; 66:1473-1481.
6. Newman SL, Bucher C, Rhodes, J, Bullock WE Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest 1990; 85:223-230
7. Schnur RA, Newman SL. The respiratory burst response to Histoplasma capsulatum by human neutrophils. Evidence for intracellular trapping. J Immunol 1990; 144: 4766-4772.
8. Kimberlin CL, Harin AR, Hempel HO, Goodman NL. Interactions between Histoplasma capsulatum and macrophages from normal and treated mice: comparison of the mycelial and yeast phases in alveolar and peritoneal macrophages. Infect Immun 1981; 34:6-10.
9. Kindler V, Sappino AP, Grau GE, Piguet PF, Vasalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56: 731-740
10. Chensue SW, Warmington KS, Ruth JH, Lincoln P Kunkel SL Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: local and regional participation of IFN-γ, IL-10 and TNF. J Immunol 1995; 154 5969-5976.
11. Allendoerfer R, Deepe GS Jr. Intrapulmonary response to Histoplasma capsulatum in gamma Interferon knockout mice. Infect Immun 1997; 65: 2564-2569.
12. Allendoerfer R, Deepe GS Jr. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 1998, 160:6072-6082.
13. Couto MA, Liu L, Lehrer RI, Ganz T. Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin Infect Immun 1994; 62: 2375-2378.
14. Newman SL, Gootee L, Gabay JE. Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J Clin Invest 1993; 92: 1422-1429
15. Zhou P, Miller G, Seder RA. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulaturrr. TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ. J Immunol 1998; 160: 1359-1368.
16. Newman SL, Kidd C. Neutrophils are essential in host defense against Histoplasma capsulatum. 97th General Meeting of the American Society for Microbiology, Miami Beach, Fla, 1997. Abstract F-98.
17. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992; 13:169-172.
18. Bullock WE, Wright SD. Role of adherence promoting receptors, CR3, LFA-1, and p150, 95 in binding of Histoplasma capsulatum by human macrophages. J Exp Med 1987; 165: 195-210.
19. Gildea L, Newman SL. Human dendritic cells phagocytose Histoplasma capsulatum (Hc) yeasts and stimulate lymphocyte proliferation in a secondary immune response. 98th Meeting of the American Society for Microbiology, Atlanta GA. 1998, Abstract F-27a.
20. Eissenberg LG, Schlesinger PH, Goldman WE. Phagosome-lysosome fusion in P388D1 macrophages infacted with Histoplasma capsulatum. J Leukocyte Biol 1988; 43: 483-91.
21. Eissenberg LG, Goldman WE, and Schlesinger PH. Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med 1993; 177: 1605-11.
22. Newman SL, Gootee L, Brunner GD, Deepe GS Jr Chloroquine induces the human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest 1994; 93: 1422-1429
23. Wu-Hsieh BA, Howard DH. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon Infect Immun 1987; 55: 1014-1016.
24. Lane TE, Wu-Hsieh BA, Howard DH. Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect Immun 1994; 61: 1468-1473.
25. Wu-Hsieh BA, Lee GS, Franco M, Hofman FM. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun 1992; 60: 4230-4238.
26. Lane TE, Otero GC, Wu-Hsieh BA, Howard DH. Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect Immun 1994; 62: 1478-1479.
27. Lane TE, Wu-Hsieh BA, Howard DH Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates. Infect Immun 1994; 62: 1940-1945.
28. Newman SL, Gootee L. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect Immun 1992; 60: 4593-4597.
29. Fleischman J, Wu-Hsieh B, Howard DH. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-γ. J Infect Dis 1990; 161: 143-145.
30. Newman SL, Gootee L, Kidd C, Ciraolo GM, Morris R. Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type I collagen matrices. J Immunol 1997, 158: 1779-1786.
31. Zhou P, Sieve MC, Tewari RP, Seder RA. Interteukin-12 modulates the protective immune response to SCID mice infected with Histoplasma capsulatum. Infect Immun 1997; 65: 936-942.
32. Patino MM, Williams DM, Ahrens J, Graybill JR. Experimental histoplasmosis in the beige mouse. J Leuco Biol 1987; 41: 228-235
33. Wheat LJ, Connolly-Springfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and a review of the literature. Medicine 1990; 69: 361-374.
34. Graybill JR. Histoplasmosis and AIDS. J Infect Dis 1988; 158: 623-628.
35. Williams DM, Graybill JR, Drutz DJ. Histoplasma capsulatum infection in nude mice. Infect Immun 1978; 21. 973-977.
36. Allendoerfer R. Unpublished observations.
37. Gomez AM, Bullock WE, Taylor CL, Deepe GS Jr. The role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect Immun 1988; 59: 330-336.
38. Allendoerfer R, Magee DM, Deepe GS Jr, Graybill JR. Transfer of protective immunity in murine histoptasmosis by a CD4+ T-cell clone. Infect Immun 1993; 61: 714-718.
39. Deepe GS Jr Role of CD8+ T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J Immunol 1994; 152. 3491-3500.
40. Wu-Hsieh B. Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum. Infect Immun 1989; 57. 3788-3792
41. Zhou P, Sieve MC, Bennett J, et al. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J Immunol 1995; 155: 785-795.
42. Lane TE, Wu-Hsieh BA, Howard DH. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun 1991; 59: 2274-2278.
43. Allendoerfer R, Brunner GD, Deepe GS Jr. Cytokine profiles in lungs of immunodeficient mice with pulmonary histoplasmosis. 98th General Meeting of the American Society for Microbiology, Atlanta, GA, 1998. Abstract F-5.
44. Trinchieri G. Interleukin-12 a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995, 13: 251-276.
45. Allendoerfer R, Boivin GP, Deepe GS Jr. Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis 1997; 175. 905-914.
46. Smith JG, Magee DM, Williams DM, Graybill JR. Tumor necrosis factor-a plays an important role in host defense against Histoplasma capsulatum. J Infect Dis 1990; 162: 1349-1353.
47. Wherry JC, Schreiber RD, Unanue ER. Regulation of gamma interferon production by natural killer cells in scid mice: Roles of tumor necrosis factor and bacterial stimuli. Infect Immun 1991; 59: 1709-1715.
48. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-a is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2: 561-572.
49. Liew FY, Millott S Tumor necrosis factor-a synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990, 145:4306-4310.
50. Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α J Immunol 1990; 145: 4290-4297
51. Saslow S, Schaeffer J. Survival of Histoplasma capsulatum in experimental histoplasmosis in mice. Proc Soc Exp Biol 1956, 91 412-414.